4.1.1 Decision pathway for Algorithm 1 – mWRD as the initial diagnostic test for TB | TB Knowledge Sharing
Cepheid | MTB/RIF Molecular Test - Xpert MTB/RIF Ultra
Predictable repeatability issues with GeneXpert-Xpert MTB/RIF (version 4) derived rifampicin resistant tuberculosis results from South India: Appreciating the limits of a technological marvel! Sanker P, Kottuthodi RP, Ambika AP, Santhosh VT, Balakrishnan
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test - The Lancet Infectious Diseases
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
Tuberculous meningitis: Diagnostic and therapeutic challenges. - Abstract - Europe PMC
Identification of Mycobacterium tuberculosis from pericardial fluid using the new Xpert MTB/RIF assay
Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia | PLOS ONE
Development of dried tube specimens for Xpert MTB/RIF proficiency testing
Use of Xpert MTB/RIF and Xpert MTB/RIF Ultra on GeneXpert 10-colour instruments: WHO policy statement. Web Annex. Study report
Comparison of Xpert MTB/RIF (G4) and Xpert Ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting - International Journal of Infectious Diseases
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda - The Lancet Microbe
Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis | BMC Microbiology | Full Text
Cepheid | MTB/RIF Molecular Test - Xpert MTB/RIF
Performance of the Xpert MTB/RIF assay as stratified by clinical... | Download Table
Predictable repeatability issues with GeneXpert-Xpert MTB/RIF (version 4) derived rifampicin resistant tuberculosis results from South India: Appreciating the limits of a technological marvel! Sanker P, Kottuthodi RP, Ambika AP, Santhosh VT, Balakrishnan
Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia | PLOS ONE
TB Online - Next-generation Xpert® MTB/RIF Ultra assay recommended by WHO
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Future Microbiology
REPORT - Performance of Xpert MTB/RIF Version G4 assay
